Skip to main content
. 2013 May 30;8(5):e64598. doi: 10.1371/journal.pone.0064598

Figure 2. High peritumoral co-expression of VEGF-C, VEGFR-1, and VEGFR-3 was correlated with poor prognosis and early recurrence.

Figure 2

Left: Cumulative overall survival (OS) curves show that patients with high peritumoral co-expression of VEGF-C, VEGFR-1, and VEGFR-3 had poorer OS (Kaplan-Meier, log-rank, p = 0.008). Right: Time to recurrence (TTR) curves showed that patients with high peritumoral co-expression of VEGF-C, VEGFR-1, and VEGFR-3 had shorter TTR (Kaplan-Meier, log-rank, p = 0.017).